NKGen Biotech (NKGN) Stock Chart & Stock Price History $0.13 0.00 (0.00%) As of 08/22/2025 03:35 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NKGen Biotech Stock Price Performance The NKGen Biotech (NKGN) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 84.59%, with a year-to-date return of -79.78%. In the past month, the stock has decreased 30.26%, reflecting recent market activity. As of the latest close, NKGen Biotech traded at $0.13 with a market cap of $5.96 million and volume of 3,139 shares. Receive NKGN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NKGen Biotech and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance0.00%1 Month Performance-30.26%3 Month Performance-54.28%Year-To-Date Performance-79.78%1 Year Performance-84.59% NKGN Stock Chart for Sunday, August, 24, 2025 NKGN Chart by TradingView NKGen Biotech Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/22/2025$0.13$0.13$0.14$0.133,139 shs$5.96 million08/21/2025$0.13$0.13$0.13$0.137,000 shs$5.96 million08/20/2025$0.13$0.13$0.13$0.13190 shs$5.96 million08/19/2025$0.13$0.13$0.15$0.1331,173 shs$5.96 million08/18/2025$0.14$0.13-5.36%$0.15$0.1331,173 shs$5.96 million08/15/2025$0.14$0.14$0.14$0.1414,577 shs$6.29 million08/14/2025$0.14$0.14$0.14$0.14971 shs$6.29 million08/13/2025$0.14$0.14$0.14$0.14971 shs$6.29 million08/12/2025$0.14$0.14$0.14$0.14400 shs$6.29 million08/11/2025$0.14$0.14$0.14$0.145,110 shs$6.29 million Get the Latest News and Ratings for NKGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NKGen Biotech and its competitors with MarketBeat's FREE daily newsletter. 08/08/2025$0.17$0.14-17.65%$0.14$0.143,581 shs$6.29 million08/07/2025$0.17$0.17$0.17$0.1770 shs$7.64 million08/06/2025$0.17$0.17$0.17$0.17799 shs$7.64 million08/05/2025$0.14$0.17+21.43%$0.17$0.17799 shs$7.64 million08/04/2025$0.14$0.14$0.14$0.142,212 shs$6.29 million08/01/2025$0.14$0.14$0.15$0.1435,417 shs$6.29 million07/31/2025$0.14$0.14$0.14$0.145,164 shs$6.29 million07/30/2025$0.14$0.14$0.14$0.1437,571 shs$6.29 million07/29/2025$0.19$0.14-26.32%$0.18$0.147,045 shs$6.29 million07/28/2025$0.19$0.19$0.19$0.19832 shs$8.54 million07/25/2025$0.19$0.19$0.22$0.1982,166 shs$8.54 million07/24/2025$0.22$0.19-13.64%$0.22$0.1982,166 shs$8.54 million07/23/2025$0.21$0.22+4.76%$0.22$0.2030,935 shs$9.89 million Related Companies NanoViricides Stock Price Chart Passage Bio Stock Price Chart BioAtla Stock Price Chart Relmada Therapeutics Stock Price Chart Lisata Therapeutics Stock Price Chart Cingulate Stock Price Chart Elevation Oncology Stock Price Chart Soligenix Stock Price Chart Promis Neurosciences Stock Price Chart Finch Therapeutics Group Stock Price Chart Receive NKGN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NKGen Biotech and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:NKGN) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NKGen Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NKGen Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access